Portfolio company
Antiva Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
4 investors
Sectors
About
This company develops topical antiviral treatments for high-risk human papillomavirus infections and pre-cancerous cervical lesions in women.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Kovina Therapeutics
The company develops antiviral therapies to treat cancers and pre-malignant infections caused by Human Papillomavirus for patients with existing infections.
Oriva
This clinical-stage biotechnology company develops therapies for chronic gynecological diseases, including endometriosis and uterine fibroids, for women requiring non-hormonal or disease-modifying treatment options.
Teal Health
This company develops at-home cervical cancer screening devices and telehealth services for women, health systems, and employers.
Antios Therapeutics
This clinical-stage biopharmaceutical company develops antiviral therapies to treat and cure patients with chronic hepatitis B virus infections.
Ananya Health
This company develops a portable cryoablation device for clinicians to treat pre-cancerous cervical lesions without using consumable cryogen gas.
Sakura MedTech
This company develops a tampon-shaped imaging device for cervical cancer screening to replace the traditional speculum for clinicians and their patients.
Altesa BioSciences
This company develops antiviral medicines for patients with chronic lung diseases such as COPD and asthma to prevent respiratory infections and illness flare-ups.
Freya Biosciences
This company develops microbial immunotherapies targeting the vaginal microbiome to treat infertility and other reproductive health conditions for women.